1. Distribution of high affinity choline transporter immunoreactivity in the primate central nervous system. Kus L, Borys E, Ping Chu Y, Ferguson SM, Blakely RD, Emborg ME, Kordower JH, Levey AI, Mufson EJ (2003) J Comp Neurol 463(3): 341-57
    › Primary publication · 12820166 (PubMed)
  2. Cell surface trafficking of the antidepressant-sensitive norepinephrine transporter revealed with an ectodomain antibody. Savchenko V, Sung U, Blakely RD (2003) Mol Cell Neurosci 24(4): 1131-50
    › Primary publication · 14697674 (PubMed)
  3. Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304). Ansah TA, Ramamoorthy S, MontaƱez S, Daws LC, Blakely RD (2003) J Pharmacol Exp Ther 305(3): 956-65
    › Primary publication · 12626658 (PubMed)
  4. Binding and transport in norepinephrine transporters. Real-time, spatially resolved analysis in single cells using a fluorescent substrate. Schwartz JW, Blakely RD, DeFelice LJ (2003) J Biol Chem 278(11): 9768-77
    › Primary publication · 12499385 (PubMed)
  5. A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity. Sung U, Apparsundaram S, Galli A, Kahlig KM, Savchenko V, Schroeter S, Quick MW, Blakely RD (2003) J Neurosci 23(5): 1697-709
    › Primary publication · 12629174 (PubMed) · PMC6741950 (PubMed Central)
  6. A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. Hahn MK, Robertson D, Blakely RD (2003) J Neurosci 23(11): 4470-8
    › Primary publication · 12805287 (PubMed) · PMC6740799 (PubMed Central)
  7. Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. Volpicelli-Daley LA, Hrabovska A, Duysen EG, Ferguson SM, Blakely RD, Lockridge O, Levey AI (2003) Mol Pharmacol 64(6): 1309-16
    › Primary publication · 14645660 (PubMed)
  8. Targeting cell surface receptors with ligand-conjugated nanocrystals. Rosenthal SJ, Tomlinson I, Adkins EM, Schroeter S, Adams S, Swafford L, McBride J, Wang Y, DeFelice LJ, Blakely RD (2002) J Am Chem Soc 124(17): 4586-94
    › Primary publication · 11971705 (PubMed)
  9. Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Nass R, Hall DH, Miller DM, Blakely RD (2002) Proc Natl Acad Sci U S A 99(5): 3264-9
    › Primary publication · 11867711 (PubMed) · PMC122507 (PubMed Central)
  10. Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. Hahn MK, Blakely RD (2002) Pharmacogenomics J 2(4): 217-35
    › Primary publication · 12196911 (PubMed)